Label updates reflect growing body of real-world evidence and regulatory confidence in the safety profile of the class of CD19- and BCMA-directed autologous CAR T cell therapies, reinforcing efforts ...
The FDA has asked Gilead Sciences, Inc. GILD, Johnson & Johnson JNJ and Novartis NVS to add “boxed warning” to the labels of their chimeric antigen receptor (CAR) T-cell immunotherapies, per Reuters.
Parse Biosciences and Codebreaker Labs partner to apply whole transcriptome single cell profiling and causal genomics at scale: Seattle Monday, December 22, 2025, 17:00 Hrs [IST] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback